The evolving role of cardiac magnetic resonance in primary mitral regurgitation: ready for prime time?
Research output: Contribution to journal › Article › peer-review
Standard
The evolving role of cardiac magnetic resonance in primary mitral regurgitation : ready for prime time? / Liu, Boyang; Edwards, Nicola C; Pennell, Dudley; Steeds, Richard P.
In: European Heart Journal Cardiovascular Imaging, Vol. 20, No. 2, 01.02.2019, p. 123-130.Research output: Contribution to journal › Article › peer-review
Harvard
APA
Vancouver
Author
Bibtex
}
RIS
TY - JOUR
T1 - The evolving role of cardiac magnetic resonance in primary mitral regurgitation
T2 - ready for prime time?
AU - Liu, Boyang
AU - Edwards, Nicola C
AU - Pennell, Dudley
AU - Steeds, Richard P
PY - 2019/2/1
Y1 - 2019/2/1
N2 - A fifth of patients with primary degenerative mitral regurgitation continue to present with de novo ventricular dysfunction following surgery and higher rates of heart failure, morbidity, and mortality. This raises questions as to why the left ventricle (LV) might fail to recover and has led to support for better LV characterization; cardiac magnetic resonance (CMR) may play a role in this regard, pending further research and outcome data. CMR has widely acknowledged advantages, particularly in repeatability of measurements of volume and ejection fraction, yet recent guidelines relegate its use to cases where there is discordant information or poor-quality imaging from echocardiography because of the lack of data regarding the CMR-based ejection fraction threshold for surgery and CMR-based outcome data. This article reviews the current evidence regarding the role of CMR in an integrated surveillance and surgical timing programme.
AB - A fifth of patients with primary degenerative mitral regurgitation continue to present with de novo ventricular dysfunction following surgery and higher rates of heart failure, morbidity, and mortality. This raises questions as to why the left ventricle (LV) might fail to recover and has led to support for better LV characterization; cardiac magnetic resonance (CMR) may play a role in this regard, pending further research and outcome data. CMR has widely acknowledged advantages, particularly in repeatability of measurements of volume and ejection fraction, yet recent guidelines relegate its use to cases where there is discordant information or poor-quality imaging from echocardiography because of the lack of data regarding the CMR-based ejection fraction threshold for surgery and CMR-based outcome data. This article reviews the current evidence regarding the role of CMR in an integrated surveillance and surgical timing programme.
KW - cardiac magnetic resonance
KW - echocardiography
KW - primary mitral regurgitation
KW - ventricular remodelling
UR - http://www.scopus.com/inward/record.url?scp=85060616521&partnerID=8YFLogxK
U2 - 10.1093/ehjci/jey147
DO - 10.1093/ehjci/jey147
M3 - Article
C2 - 30364971
VL - 20
SP - 123
EP - 130
JO - European Heart Journal Cardiovascular Imaging
JF - European Heart Journal Cardiovascular Imaging
SN - 2047-2404
IS - 2
ER -